Trial Profile
A Single-center Open, Randomized, Controlled Study to Compare the Apapitatin Combined With SOX and SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Aug 2020
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Rivoceranib (Primary) ; Tegafur (Primary)
- Indications Carcinoma; Gallbladder cancer
- Focus Therapeutic Use
- 22 Oct 2018 New trial record